Anchyra Partners LLC Invests $1.36 Million in CME Group Inc. $CME

Key Points

• Anchyra Partners LLC bought a new position of 4,980 shares (~$1.36M) in CME Group in Q4; overall institutional ownership is about 87.75%, with Vanguard holding roughly 35.9M shares (~$9.8B).
• CME reported record Q1 revenue and surging trading volumes, beating estimates with EPS $3.36 (vs. $3.11 expected) and revenue $1.88B (vs. $1.77B expected), driven by increased hedging and risk‑management activity.
• The company raised its quarterly dividend to $1.30 (annualized $5.20, ~1.8% yield), while analysts have trimmed price targets but the consensus rating remains a "Moderate Buy" with a target near $306.71.

Anchyra Partners LLC purchased a new position in CME Group Inc. (NASDAQ:CME - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 4,980 shares of the financial services provider's stock, valued at approximately $1,360,000.

Other large investors also recently bought and sold shares of the company. Sanders Capital LLC bought a new stake in CME Group in the third quarter worth $1,006,932,000. Strive Asset Management LLC bought a new position in shares of CME Group during the third quarter valued at $636,487,000. Mawer Investment Management Ltd. increased its holdings in shares of CME Group by 107.2% during the third quarter. Mawer Investment Management Ltd. now owns 1,502,752 shares of the financial services provider's stock valued at $406,029,000 after acquiring an additional 777,571 shares in the last quarter. Viking Global Investors LP purchased a new position in shares of CME Group in the 2nd quarter worth about $164,648,000. Finally, Vanguard Group Inc. raised its position in shares of CME Group by 1.7% in the 4th quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider's stock worth $9,802,366,000 after purchasing an additional 588,509 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes: CME reported record Q1 revenue and a surge in trading volumes, driven by higher hedging and risk-management activity — a core driver of futures and options trading revenue. Article Title
• Positive Sentiment: Earnings-call commentary backs the volume story: Management emphasized broad-based demand and rising market risk that is increasing hedging flows — a positive outlook for transaction-driven revenue. Article Title Article Title
• Positive Sentiment: Full earnings transcript available for deeper color: Investors can review management's detail on volume drivers and segment performance. Article Title
• Neutral Sentiment: Multiple analysts trimmed price targets but kept constructive ratings: Deutsche Bank cut its PT to $322 (keeps buy) and TD Cowen cut to $323 (keeps buy); Morgan Stanley trimmed to $353 but retained overweight — these lower targets reflect model updates despite continued positive ratings. Article Title Article Title Article Title
• Neutral Sentiment: No meaningful short-interest signal: the short-interest data published for April is effectively zero/unchanged and does not explain the move. (No linked article.)
• Negative Sentiment: Goldman maintains a sell rating and lowered its PT to $267 — the most bearish big-bank view in the group and a direct negative for sentiment. Article Title
• Negative Sentiment: Mixed market reaction and some headline takes that Q1 sales missed analyst expectations or that the stock looks expensive post-earnings — these narratives can pressure short-term price action despite strong volume trends. Article Title Article Title

Insider Transactions at CME Group

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of the company's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares in the company, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of the stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the transaction, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. This represents a 8.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 8,539 shares of company stock valued at $2,713,821. Corporate insiders own 0.30% of the company's stock.

CME Group Stock Performance

Shares of CME stock opened at $285.02 on Monday. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a 50 day moving average price of $304.51 and a 200-day moving average price of $286.38. CME Group Inc. has a 52 week low of $257.17 and a 52 week high of $329.16. The firm has a market capitalization of $102.22 billion, a PE ratio of 24.32, a P/E/G ratio of 3.45 and a beta of 0.26.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts' consensus estimates of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the prior year, the firm earned $2.80 earnings per share. The firm's revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, equities research analysts expect that CME Group Inc. will post 12.24 earnings per share for the current year.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Tuesday, March 10th. This is a positive change from CME Group's previous quarterly dividend of $1.25. CME Group's payout ratio is currently 44.37%.

Analyst Upgrades and Downgrades

Several analysts recently commented on CME shares. Barclays cut their price objective on shares of CME Group from $343.00 to $316.00 and set an "equal weight" rating on the stock in a research report on Thursday. Raymond James Financial lifted their target price on shares of CME Group from $310.00 to $320.00 and gave the stock an "outperform" rating in a report on Monday, April 6th. Morgan Stanley dropped their target price on shares of CME Group from $362.00 to $353.00 and set an "overweight" rating on the stock in a research note on Thursday. Weiss Ratings upgraded shares of CME Group from a "buy (b+)" rating to a "buy (a-)" rating in a report on Monday, March 2nd. Finally, TD Cowen reduced their price target on shares of CME Group from $340.00 to $323.00 and set a "buy" rating for the company in a research report on Thursday. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $306.71.

About CME Group

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.